Latest California Healthline Stories
Watch: Why Infusion Drugs Come With Sticker Shock
The story of an Ohio mom who faced an outrageous bill for a new medicine for multiple sclerosis is the latest installment in the “Bill of the Month” series, an ongoing crowdsourced investigation by KHN and NPR.
Chronically Ill, Traumatically Billed: The $123,000 Medicine For MS
Shereese Hickson’s doctor wanted her to try the infusion drug Ocrevus for her multiple sclerosis. Even though Hickson is trained as a medical billing coder, she was shocked to see two doses of the drug priced at $123,019, with her share set at $3,620.
Comprar planes de salud de corto plazo, ¿es inteligente o no?
La administración Trump impulsa estos planes que no cumplen con los requisitos de ACA de proteger a los pacientes con condiciones preexistentes.
Buyers Of Short-Term Health Plans: Wise Or Shortsighted?
Policyholders reason that their health is good — for now — and they don’t see the need for costly comprehensive coverage. Detractors say the plans undermine the Affordable Care Act, and agents advise reading the fine print. “You basically have to be in perfect health,” says one.
Measure To Cap Dialysis Profits Pummeled After Record Spending By Industry
The dialysis industry raised nearly $111 million in a successful bid to defeat the measure, which also was opposed by hospitals and doctors. The union that sponsored the measure collected about one-sixth that amount.
Beyond The Buzz: What Do Americans Mean By ‘Medicare-For-All’?
KHN’s news analysis on “Medicare-for-all” sparks a broader conversation.
Podcast: KHN’s ‘What The Health?’ Open Enrollment And A Midterm Preview
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Joanne Kenen of Politico discuss the start of open enrollment for individual health insurance plans for 2019 and preview what next week’s midterm elections might mean for health policy. Plus, Barbara Feder Ostrov of KHN and California Healthline talks to Julie about the latest NPR-KHN “Bill of the Month” feature.
Ad Check: What Happens If California Limits Dialysis Center Profits?
Both sides in the contentious and expensive battle over California’s Proposition 8 are cherry-picking the facts ahead of Tuesday’s vote as dialysis companies spend record amounts to persuade voters through ads.
Pricey Precision Medicine Often Financially Toxic For Cancer Patients
Medical treatments targeting the DNA in tumor cells are celebrated, but insurers often won’t cover the skyrocketing cost.
Billions In ‘Questionable Payments’ Went To California’s Medicaid Insurers And Providers
The money was paid on behalf of more than 400,000 people who may have been ineligible for the public program, a state audit found. One had been dead for four years before payments stopped.